Clinical Trial: AI-based Predictive and Interventional System for Early Detection of Non-compliance Risks With Oral Therapies in Lymphoma Patients.

U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT07546188) titled 'AI-based Predictive and Interventional System for Early Detection of Non-compliance Risks With Oral Therapies in Lymphoma Patients.' on April 08.

Brief Summary: This research forms part of a continuous quality improvement initiative. It aims to assess patient compliance of oral therapies by artificial intelligence. It could overcome the limitations of current practices and enhance the responsiveness and accuracy of clinical interventions.

Study Start Date: Feb. 15

Study Type: OBSERVATIONAL

Condition: Lymphoma, Non-Hodgkin Care Coordination

Intervention: OTHER: Retrospective Group

For the retrospective group of 20 patients. ...